genprowebdirectory
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
DNA
Multiple Sclerosis Provoked by DNA Traps That Promote Immune Cell Specialization
Neurological Disorders
Neuro Overactivity Linked to Certain Schizophrenia Symptoms
Inflammatory Diseases
Researchers Uncover Link between Gut Microbiome and Inflammatory Diseases
Animal Models
Five-Drug Cocktail and Wearable Bioreactor Enable Regrowth of Amputated Adult Frog…
Blood Disorders
Synthetic Platelets Quickly Stop Bleeding from Injuries in Rodents
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
Soft Off-Gas Sensor for CHO Cultures
Bioprocessing
Using Waddington’s Landscape to Bioprocess Stem Cells
Bioprocessing
Biomanufacturing Islands for Faster, More Efficient Cell Line Development
Artificial Intelligence
Machine Learning to Optimize Product Quality Measurement
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Coronavirus
Top 11 Best Selling COVID-19 Vaccines and Drugs of H1 2021
A-Lists
Top 10 Spatial Biology Companies
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Neurological Disorders
ALS
ALS
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
ALS
ALS-Linked TDP-43 Aggregates Seen Clearly Enough to Raise Treatment Hopes
ALS
Steering Stem Cells to Repair Sites Using Inflammo-Free Inflammo-Attraction
Sponsored
Working with ALS Mice: Guidelines for Preclinical Testing and Colony Management
ALS
Neurodegenerative Treatments Build to a Tipping Point
ALS
Is ALS More Genetically Driven than Once Thought?
ALS
Sanofi, Denali Launch $1B+ Alliance to Develop RIPK1 Inhibitors for Neurological,...
ALS
Amyloids Shown to Also Play Beneficial Role in Developing Healthy Muscle...
ALS
Axovant Licenses Benitec Gene Therapy Candidates for OPMD, Neurological Disorders
ALS
Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase...
ALS
Neuraltus Weighs Future of Lead Candidate NP001 after Failure in Phase...
ALS
Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success
ALS
Novel Research Model Offers Hope to ALS and MS Patients
ALS
Hardening of the RNA Condensates May Solidify Neurodegeneration
ALS
Hope for ALS Patients Comes from New Understanding of RNA Metabolism...
ALS
CRISPR Screen Identifies Genetic Modifiers of ALS
1
2
3
Page 1 of 3
Scroll Up
![Flex Pharma cites unspecified “oral tolerability concerns” in halting Phase II trials of FLX-787 in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT). [© whitehoune / Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/170123090806_1_900x6009916143062-324x160.jpg "Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase II Trials in ALS, CMT")
![The hnRNP A1B is expressed in the central nervous system and forms cytoplasmic aggregates in ALS patient neurons. [CRCHUM]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar19_2018_CRCHUM_hnRNPA1B2262381965-324x160.jpg "Hope for ALS Patients Comes from New Understanding of RNA Metabolism Misregulation")
